Delivery Order SPE2DB20D3103-SPE2DB22FL3D6

Award Date 10/8/21
Potential Completion Date 10/12/21
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of 4,562,765,670 units of the pharmaceutical product BRILINTA 90 MG TABLET 60S. The $3,145.20 firm-fixed-price contract has an ultimate completion date of November 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,554,721,390 units of BRILINTA 90 MG TABLET 60S. The firm-fixed-price delivery order, valued at $3,412.83, has a completion date of September 10, 2021. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
This federal contract award is for the delivery of 4,555,061,488 tablets of the cardiovascular medication BRILINTA 90 MG to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 12, 2021 with a completion date of October 13, 2021. The award has a ceiling value of $16,509.38 and is structured as a firm fixed-price delivery order. This contract is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 60 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,248.39 and a completion date of April 10, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRILINTA 60 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $1,542.65 and a completion date of December 13, 2022. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract, valued at $1,317.61, has a firm fixed price and a completion date of January 18, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a ceiling value of $1,789.78 and a period of performance through August 24, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $1,891.61 and was awarded on May 10, 2022, with a completion date of May 11, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $17,320.52 and an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a ceiling value of $8,555.39 and a performance period through April 19, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FL3D6
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,555,041,364 units of the pharmaceutical product BRILINTA 90 MG Tablet 60S, with a ceiling value of $1,061.23. The award date was October 8, 2021, and the ultimate completion date is October 12, 2021.

The contract is not designated as a set-aside and was competed openly. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 9:49 AM